{"paper_id":"008c0a4c-a63c-4b2e-9d1c-ef4bcbac72b7","body_text":"Abstract\nThe growing number of spatial transcriptomics (ST) datasets enables comprehensive multi-modal characterization of cell types across diverse biological and clinical contexts. However, integration across patient cohorts remains challenging, as local microenvironment, patient-specific variability, and technical batch effects can dominate signals. Here, we hypothesize that combining specialized transcriptomics correction methods with deep representation learning can jointly align morphology, transcriptomics, and spatial information across multiple tissue samples. This approach benefits from recent transcriptomics and pathology foundation models, projecting cells into a shared embedding space where they cluster by cell type rather than dataset-specific conditions. Applying this framework to 18 skin melanoma, 12 human brain, and 4 lung cancer datasets, we demonstrate that it outperforms conventional batch-correction approaches by 58%, 38%, and 2-fold, respectively. Together, this framework enables efficient integration of multi-modal ST data across modalities and samples, facilitating the systematic discovery of conserved cellular programs and spatial niches while remaining robust to cohort-specific batch effects.\nCode availability https://github.com/ratschlab/aestetik\nCompeting Interest Statement\nV.H.K reports being an invited speaker for Sharing Progress in Cancer Care (SPCC) and Indica Labs; advisory board of Takeda; and sponsored research agreements with Roche and IAG, all unrelated to the current study. V.H.K. is a participant in a patent application on the assessment of cancer immunotherapy biomarkers by digital pathology; a patent application on multimodal deep learning for the prediction of recurrence risk in cancer patients, and a patent application on predicting the efficacy of cancer treatment using deep learning all unrelated to the current work. GR is a participant in a patent application on matching cells from different measurement modalities which is not directly related to the current work. Moreover, G.R. is a cofounder of Computomics GmbH, Germany, and one of its shareholders.\nFootnotes\njusdai{at}ethz.ch, kalin.nonchev{at}inf.ethz.ch, viktor.koelzer{at}usb.ch, raetsch{at}inf.ethz.ch","source_license":"CC-BY-4.0","license_restricted":false}